GAP ANALYSIS REPORT tuberculosis component September 2011. INTRODUCTION.
PowerPoint Slideshow about 'GAP ANALYSIS REPORT tuberculosis component September 2011' - milos
An Image/Link below is provided (as is) to download presentation
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
The Ministry of Health and Social Welfare (MOHSW) through the National TB/Leprosy Programme (NTLP) in collaboration with Programme for Appropriate Technology in Heath (PATH) commissioned a consultant – Prof G. B. Milgiori and Mr. Alberto Matteelli Giusto of WHO Collaborating Centre, Tradate Varese Italy
Other partners involved were Medical Sciences for Health (MSH)
The Gap Analysis was conducted from 4 – 8 July, 2011 in 3 Municipalities in Dar es Salaam and Partners Supporting TB and TB/HIV control in the country
Dissemination of findings was done on 11th July, 2011 at Courtyard Hotel and was attended by more than 30 stakeholders and partners. The list of attendants is available
Comments from the dissemination meeting were incorporated into the final report.
This dissemination is intended to inform TNCM members of the TB gaps highlighted by the GAP analysis and seek directives on how to resolve them
Difficult to assess trends in partners funding. Aggregation of US govt support with other sources (German Leprosy Relief Association (GLRA), World Health Organization (WHO), Global Development Finance (GDF) and World Bank not enough
Solution1: NTLP to describe who is funding what, the disaggregated support by US Gov, GLRA, WHO, GDF, WB & UNITAID as preliminary step of the writing process, following ICC meeting with partners.
Solution2: NTP needs to quantify the amount allocated for TB laboratories within the WB proposal for Tanzania.
In view of the delay in signing the Round 6 Phase II grant and slow spending in Phase I, the TRP is concerned about absorption capacity.
Solution 1: NTLP to describe the process, difficulties encountered and remedial actions undertaken.
Solution 2: Describe role of the focal person(s) recruited by MoHSW to coordinate GF implementation (disbursements, technical and financial reporting) and any other GF obligations needs to be emphasized.
Many items are incorrectly classified per cost category hindering appropriate assessment (e.g. no Procurement and Supply Management cost has been documented) and Many unit costs for pharmaceuticals and equipment are set substantially higher than international standards
Solutions: .NTLP to identify the items concerned and capture it in R11 proposal with consultants’ support and overall input by SMH
Solutions: NTP to identify the items concerned and capture correct costs it in R11 proposal with consultants and MSH support
Indicators to output of activities that do not really reflect the performance of the program in terms of coverage of target groups and quality of services provided should be removed from the performance framework.
Include lab performances (EQA AFB, validation of DST 1st and 2nd line)